$ cat ./records/gates-foundations-challenge-grants-drive-guinea-worm-to-the-brink-2008.txt
Gates Foundation's Challenge Grants Drive Guinea Worm to the Brink of Eradication
[RECORD.TXT] · cat --full
The Gates Foundation has been a major backer of the Carter Center's decades-long campaign to wipe out Guinea worm disease, including a $40 million challenge grant in 2008 — then the largest in Carter Center history — to spur matching donations. Once afflicting millions across Africa and Asia, the parasitic disease has been driven to the verge of becoming only the second human disease ever eradicated, with cases falling to single digits. It stands among the clearest successes of Gates-funded disease-elimination work.
Source: https://www.cartercenter.org/news/pr/gates_120508.html
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Bill Gates Lobbies Congress to Lift H-1B Visa Caps, Drawing Worker-Advocate Criticism
Next →
Gates Renames His Personal Office bgC3, the Seed of Gates Ventures
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.